Lupin acquires Gavis and Novel Labs in US
Lupin Limited has signed an agreement to acquire privately held Gavis Pharmaceuticals LLC and Novel Laboratories Inc (Gavis) for a value of USD 880 million. […]
acquisitions
Lupin acquires Zao Biocom of Russia
Lupin today has acquired Zao Biocom, a generic pharma company in Russia to make its foray into the Russian market. It is estimated that Russia […]